Personalized Medicine: Pharmacokinetics by Youssef Daali

Get full text

Pharmacokinetics of Snake Venom by Suchaya Sanhajariya, Stephen B. Duffull, Geoffrey K. Isbister

Subjects: Get full text

The Two Faces of Pharmacokinetics by Aldo Rescigno

“…There are two main branches of Mathematics: Calculus and Geometry; in Physics there are Constructive Theories and Principle Theories. Similarly in Pharmacokinetics we can build models with two opposite approaches, the bottom-up and the top-down point of view. …”
Get full text

Pharmacokinetic Studies of Radiopharmaceuticals by A. S. Lunev, K. A. Lunyova, O. E. Klementyeva

Subjects: Get full text

Pharmacokinetics and Pharmacogenetics of Dabigatran by A. V. Savinova, V. S. Dobrodeeva, M. M. Petrova, R. F. Nasyrova, N. A. Shnayder

Subjects: Get full text

Pharmacokinetics of intravenous amodiaquine. by White, N, Looareesuwan, S, Edwards, G, Phillips, R, Karbwang, J, Nicholl, D, Bunch, C, Warrell, D

“…The plasma concentration-time profiles were biphasic with the following estimated pharmacokinetic parameters (geometric mean; range) alpha = 1.87 (0.60-8.52) h-1, beta = 0.069 (0.021-0.265) h-1, V1: 4.6 (0.5-29.3) 1 kg-1, Vss: 38.3 (3.7-127.9) 1 kg-1 and systemic clearance CL (1.6-17.3) 1 kg-1 h-1. …”

Ondansetron and alcohol pharmacokinetics. by Johnson, B, Rue, J, Cowen, P

Pharmacokinetics and pharmacodynamics of curcumin. by Sharma, R, Steward, W, Gescher, A

Clinical pharmacokinetics of mefloquine. by Karbwang, J, White, N

“…Several assay methodologies have been developed, but high performance liquid chromatography has been the most used in recent pharmacokinetic studies. These have shown in healthy volunteers that mefloquine is absorbed with a half-life of 1 to 4 hours and a time to peak concentration of 7 to 24 hours (median 16.7 hours). …”

Utilization of Physiologically Based Pharmacokinetic Modeling in Pharmacokinetic Study of Natural Medicine: An Overview by Qiuyu Jia, Qingfeng He, Li Yao, Min Li, Jiaying Lin, Zhijia Tang, Xiao Zhu, Xiaoqiang Xiang

Subjects: “…physiologically based pharmacokinetic modeling…”
Get full text

Oseltamivir Population Pharmacokinetics in the Ferret: Model Application for Pharmacokinetic/Pharmacodynamic Study Design. by Micaela B Reddy, Kuo-Hsiung Yang, Gauri Rao, Craig R Rayner, Jing Nie, Chandrasena Pamulapati, Bindumadhav M Marathe, Alan Forrest, Elena A Govorkova

“…The ferret is a suitable small animal model for preclinical evaluation of efficacy of antiviral drugs against various influenza strains, including highly pathogenic H5N1 viruses. Rigorous pharmacokinetics/pharmacodynamics (PK/PD) assessment of ferret data has not been conducted, perhaps due to insufficient information on oseltamivir PK. …”
Get full text

First-in-human study to investigate the safety and pharmacokinetics of salvianolic acid A and pharmacokinetic simulation using a physiologically based pharmacokinetic model by Jinliang Chen, Zourong Ruan, Honggang Lou, Dandan Yang, Rong Shao, Yichao Xu, Xinhua Hu, Bo Jiang

Subjects: Get full text

Concept and utility of population pharmacokinetic and pharmacokinetic/pharmacodynamic models in drug development and clinical practice by Roganović Maša, Homšek Ana, Jovanović Marija, Topić-Vučenović Valentina, Ćulafić Milica, Miljković Branislava, Vučićević Katarina

Subjects: Get full text

Whole-Body Pharmacokinetics and Physiologically Based Pharmacokinetic Model for Monomethyl Auristatin E (MMAE) by Hsuan Ping Chang, Yuen Kiu Cheung, Dhaval K. Shah

Subjects: Get full text

Population pharmacokinetic analysis of rivaroxaban in children and comparison to prospective physiologically‐based pharmacokinetic predictions by Stefan Willmann, Katrin Coboeken, Yang Zhang, Hannah Mayer, Ibrahim Ince, Emir Mesic, Kirstin Thelen, Dagmar Kubitza, Anthonie W. A. Lensing, Haitao Yang, Peijuan Zhu, Wolfgang Mück, Henk‐Jan Drenth, Jörg Lippert

“…Physiologically‐based pharmacokinetic (PBPK) and population pharmacokinetic (PopPK) modeling were used throughout the pediatric development of rivaroxaban according to the learn‐and‐confirm paradigm. …”
Get full text

Application of Physiologically Based Pharmacokinetic Modeling to Predict Maternal Pharmacokinetics and Fetal Exposure to Oxcarbazepine by Lixia He, Meng Ke, Wanhong Wu, Jiarui Chen, Guimu Guo, Rongfang Lin, Pinfang Huang, Cuihong Lin

Subjects: Get full text

Population Pharmacokinetics of Hydroxychloroquine and 3 Metabolites in COVID-19 Patients and Pharmacokinetic/Pharmacodynamic Application by Jean Claude Alvarez, Benjamin Davido, Pierre Moine, Isabelle Etting, Djillali Annane, Islam Amine Larabi, Nicolas Simon

“…We develop a population pharmacokinetic model for hydroxychloroquine (HCQ) and three of its metabolites (desethylhydroxychloroquine, Des HCQ; desethylchloroquine, DesCQ; and didesethylchloroquine, didesCQ) in COVID-19 patients in order to determine whether a pharmacokinetic (PK)/pharmacodynamic (PD) relationship was present. …”
Get full text

Pharmacokinetic-pharmacodynamic modeling and simulation / by 192959 Bonate, Peter L.

Subjects: “…Pharmacokinetics…”

Pharmacokinetics and metabolism in drug design / by 464017 Smith, Dennis A., Waterbeemd, Han Van De, Walker, Don K.

Subjects: “…Pharmacokinetics…”

Basic pharmacokinetics [compact disc] / by 317664 Hedaya, Mohsen A.

Subjects: “…Pharmacokinetics…”